1. Home
  2. BMEA vs TLYS Comparison

BMEA vs TLYS Comparison

Compare BMEA & TLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomea Fusion Inc.

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.25

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Logo Tilly's Inc.

TLYS

Tilly's Inc.

HOLD

Current Price

$4.68

Market Cap

128.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMEA
TLYS
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
132.6M
128.1M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
BMEA
TLYS
Price
$1.25
$4.68
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
★ $9.83
$2.00
AVG Volume (30 Days)
★ 2.1M
1.1M
Earning Date
05-12-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.19
62.34
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.66
Revenue Next Year
N/A
$1.74
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.87
$1.14
52 Week High
$2.99
$6.25

Technical Indicators

Market Signals
Indicator
BMEA
TLYS
Relative Strength Index (RSI) 33.03 59.17
Support Level $1.17 $3.68
Resistance Level $1.47 $4.96
Average True Range (ATR) 0.15 0.28
MACD -0.08 0.02
Stochastic Oscillator 0.00 73.33

Price Performance

Historical Comparison
BMEA
TLYS

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley, among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

Share on Social Networks: